Fig. 4From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)Full scan mass spectrum (Q1MS) of P-bi-TAT by in-source CID in positive modeBack to article page